214360-71-1 Usage
Uses
Used in Pharmaceutical Research:
Benzoic acid, 2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) is used as a building block in the development of pharmaceuticals for its versatile reactivity and unique structural features.
Used in Agrochemical Development:
Benzoic acid, 2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) is used in the development of agrochemicals, contributing to the creation of new and improved products for agricultural applications.
Used in Materials Science:
Benzoic acid, 2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) is utilized in materials science to develop new materials with enhanced properties.
Used as a Cross-Coupling Reagent:
In organic reactions, this compound serves as a cross-coupling reagent, facilitating the synthesis of complex organic molecules and contributing to advancements in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 214360-71-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,3,6 and 0 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 214360-71:
(8*2)+(7*1)+(6*4)+(5*3)+(4*6)+(3*0)+(2*7)+(1*1)=101
101 % 10 = 1
So 214360-71-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H18BNO4/c1-12(2)13(3,4)19-14(18-12)8-5-6-10(15)9(7-8)11(16)17/h5-7H,15H2,1-4H3,(H,16,17)
214360-71-1Relevant articles and documents
HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE
-
Paragraph 0520; 0521; 0522, (2016/12/16)
Disclosed are compounds having the formula: wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP1, TLL1 and/or TLL2 activity.
HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE
-
Page/Page column 104; 105, (2015/07/23)
Disclosed are compounds having the formula (I): wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP1, TLL1 and/or TLL2 activity.